Angiotensin‐Converting Enzyme Inhibitor Prescription for Patients With Single Ventricle Physiology Enrolled in the NPC‐QIC Registry

BACKGROUND: The routine use of angiotensin‐converting enzyme inhibitors (ACEI) during palliation of hypoplastic left heart syndrome is controversial. We sought to describe ACEI prescription in the interstage between stage 1 palliation (stage I Norwood procedure) discharge and stage 2 palliation (sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, Jesse E., Brown, David W., Hanke, Samuel P., Bates, Katherine E., Tweddell, James S., Hill, Garick, Anderson, Jeffrey B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660880/
https://www.ncbi.nlm.nih.gov/pubmed/32384002
http://dx.doi.org/10.1161/JAHA.119.014823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660880/
https://www.ncbi.nlm.nih.gov/pubmed/32384002
http://dx.doi.org/10.1161/JAHA.119.014823

Ejemplares similares